Tag: Wainwright
Poxel Announces Upcoming Attendance at the 2nd Annual HC Wainwright Kidney Disease Conference – 07/18/2023 at 07:30
LYON, France, July 18, 2023 – POXEL SA (Euronext: POXEL – FR0012432516), a clinical-stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH)…
Presenting Aptorum Group Limited at the HC Wainwright Annual Global Investment Conference to be held September 13-16, 2022
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM), a clinical-stage biopharmaceutical company dedicated to addressing unmet medical needs in oncology, autoimmune diseases and infectious diseases, today announces that Mr. Darren…
GlycoMimetics, Inc.: HC Wainwright Stays Buy
Marketzone with MT Newswires 2022 All the news about GLYCOMIMETICS, INC. Analyst Recommendations for GLYCOMIMETICS, INC. 2022 turnover –…
Transcat, Inc.: HC Wainwright favorable on the file
Marketzone with MT Newswires 2022 All the news about TRANSCAT, INC. Analyst Recommendations for TRANSCAT, INC. CA 2023 222M…
Fulcrum Therapeutics, Inc.: HC Wainwright Maintains Buy Recommendation
Marketzone with MT Newswires 2022 All the news about FULCRUM THERAPEUTICS, INC. Analyst Recommendations on FULCRUM THERAPEUTICS, INC. 2022…
Celyad Oncology will give a presentation at the HC Wainwright Global Investment Conference – 05/17/2022 at 22:01
Mont-Saint-Guibert, Belgium – Celyad Oncology SA (Euronext & Nasdaq: CYAD) (the “Company”), a clinical-stage biotechnology company focused on the research and development of CAR T (Chimeric Antigen Receptor) cell therapies…
ERYTECH will hold a presentation at the HC Wainwright Global Investment conference – 05/17/2022 at 22:05
ERYTECH hold a presentation to the conference HC Wainwright Global Investment Lyons ( France ), and Cambridge, MA (US) the 1 7 May 2 022 – ERYTECH Pharmaceuticals (Euronext &…
ERYTECH will hold a presentation at the HC Wainwright Global Investment conference – 05/17/2022 at 22:05
If you wish to receive all of the company’s financial communications in real time, you can register directly by email at the following address: [email protected] Lyon (France), and Cambridge, MA…
Annexon, Inc.: HC Wainwright optimistic on the file
Marketzone with MT Newswires 2022 All the news about ANNEXON, INC. ANNEXON, INC. Analyst Recommendations 2022 turnover – –…
MaaT Pharma announces its participation in the HC Wainwright BioConnect 2022 virtual conference – 03/01/2022 at 19:02
Lyon, France, January 3, 2022 – 7:00 p.m. CET – MaaT Pharma (EURONEXT: “MAAT”), a French biotechnology company in advanced clinical stages, pioneer in the development of drugs in the…